Sudeepa Bhattacharyya

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

High Impact

Professor (adjunct appointment)

Arkansas State University primary UA Little Rock NCTR University of Arkansas UAMS

Also affiliated: Arkansas Children's Hospital (2012–2018); San Francisco VA Medical Center (2020); United States Food and Drug Administration (2010–2012); University of British Columbia (2002); Pacific Northwest National Laboratory (2002); Emory University (2024); University of Alberta (2002–2003); Duke University (2020); University of California, San Francisco (2020); University of Toronto (2002); University of Arkansas Medical Center (2007–2018); Environmental Molecular Sciences Laboratory (2002); Helmholtz Munich (2020); Rosa (United States) (2020); Institute of Bioinformatics and Systems Biology (2020); GGZ inGeest (2024); Arkansas Children's Nutrition Center (2016–2018); Amsterdam University Medical Centers (2024); Arkansas Biosciences Institute (2020–2025); Indiana University Indianapolis (2020); Indiana University School of Medicine (2020); Arkansas Children's Research Institute (2013–2019); Indiana University – Purdue University Indianapolis (2020); University of Missouri–Kansas City (2024–2025); University of Pennsylvania (2020); University of California, Davis (2020); Texas A&M University (1998); Amsterdam UMC Location Vrije Universiteit Amsterdam (2024); Icahn School of Medicine at Mount Sinai (2020)

26 h-index 100 pubs 3,212 cited

Research Areas

Biomedical Subjects

Links

ORCID Lab Website

OverviewAI-generated summary

Sudeepa Bhattacharyya's research focuses on the application of metabolomic and proteomic techniques to investigate disease mechanisms. Her work has explored altered metabolic profiles in conditions such as Alzheimer's disease, examining changes in bile acids, serum triglycerides, and acylcarnitines. Bhattacharyya has also investigated the metabolic signatures associated with major depressive disorder, including the impact of psychotropic medications like citalopram and escitalopram.

Her research extends to the use of metabolomics and proteomics for diagnostic purposes, including the diagnosis of pancreatic cancer using serum proteomic profiling. Bhattacharyya has co-led efforts in campus cyberinfrastructure modernization, receiving funding from the National Science Foundation for this initiative. Her scholarship metrics include an h-index of 27, with over 3,300 citations across more than 100 publications. She actively collaborates with researchers from the University of Arkansas for Medical Sciences, including Fred Prior and Kevin W. Sexton.

Metrics

h-index: 26
Publications: 100
Citations: 3,212

Positions

Professor (adjunct appointment) 2025–present

University of Arkansas for Medical Sciences Biomedical Informatics ORCID
Full Professor (tenured) 2025–present

University of Missouri–Kansas City Biomedical and Health Informatics ORCID
Associate Professor 2019–2025

Arkansas State University Arkansas Biosciences Institute & Biological Sciences ORCID
Associate Professor (tenured) 2017–2019

University of Arkansas for Medical Sciences Biomedical Informatics ORCID
Assistant Professor 2012–2017

University of Arkansas for Medical Sciences Pediatrics (Biostatistics Core) ORCID
Commisioner's Fellow 2009–2011

USFDA National Center for Toxicological Research ORCID
lead Bioinformatics Scientist 2008–2009

Stemina Biomarker Discovery (United States) ORCID
Post Doctoral Fellow 2007–2008

University of Arkansas for Medical Sciences Center for Orthopedic Research ORCID

Selected Publications

Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort (2025)

Translational Psychiatry 13 citations DOI OpenAlex
Evaluating maternal drug use disparities, risk factors and outcomes in Northeast Arkansas: a pre, during, and post-COVID-19 pandemic analysis (2025)

BMC Public Health 2 citations DOI OpenAlex
Metabolomics signatures of serotonin reuptake inhibitor (escitalopram), serotonin norepinephrine reuptake inhibitor (duloxetine) and cognitive-behavioral therapy on key neurotransmitter pathways in major depressive disorder (2025)

Journal of Affective Disorders 7 citations DOI OpenAlex
Medication use is associated with distinct microbial features in anxiety and depression (2025)

Molecular Psychiatry 17 citations DOI OpenAlex
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort (2024)

Research Square DOI OpenAlex
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder (2024)

medRxiv 2 citations DOI OpenAlex
Medication Use is Associated with Distinct Microbial Features in Anxiety and Depression (2024)

bioRxiv (Cold Spring Harbor Laboratory) 3 citations DOI OpenAlex
Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort (2024)

medRxiv DOI OpenAlex
Social Determinants of Health Data Quality at Different Levels of Geographic Detail (2023)

Studies in health technology and informatics 10 citations DOI OpenAlex
Social Determinants of Health Data Quality at Different Levels of Geographic Detail (2023)

medRxiv 3 citations DOI OpenAlex
Repeatable enhancement of healthcare data with social determinants of health (2022)

Frontiers in Big Data 3 citations DOI OpenAlex
Gut Microbiome-Linked Metabolites in the Pathobiology of Major Depression With or Without Anxiety—A Role for Bile Acids (2022)

Frontiers in Neuroscience 72 citations DOI OpenAlex
Covid-19 Positivity Differences Among Patients of a Rural, Southern US State Hospital System Based on Population Density, Rural-Urban Classification, and Area Deprivation Index (2022)

Studies in health technology and informatics 4 citations DOI OpenAlex
Metabolomic and inflammatory signatures of symptom dimensions in major depression (2022)

Brain Behavior and Immunity 105 citations DOI OpenAlex
Automated Enhancement and Curation of Healthcare Data (2022)

medRxiv DOI OpenAlex